Pioneering scientific breakthroughs in cancer care
By connecting insights from patients, practitioners, clinical trials, health systems and managed care partners, Labcorp Oncology helps you improve outcomes through the promise of precision medicine.
For Cancer Care Teams
Our comprehensive hematology test menu and expertise equip you with detailed reports and deep scientific insights to provide you with the most accurate diagnoses and risk stratifications for your patients.
- We offer a comprehensive portfolio of tests ranging from morphology and cytogenetics to single gene analysis and next-generation sequencing.
- Over forty-five board-certified hematopathologists and PhD geneticists focus on our hematopathology services including results analysis, reporting, and consultative support.
- With over 375,000 hematology/oncology tests performed annually, you and your patients will benefit from our streamlined processes and expertise in the analysis and reporting of a vast variety of cases.
- Our comprehensive testing services provide you with information to help take decisive clinical actions for your patients. Additionally, our workflow makes it possible to add follow-up tests on existing patient samples, typically without requiring another draw or biopsy.
We invite you to explore:
For Biopharma Partners
With our integrated oncology drug development team, you have a committed partner with the capabilities, expertise and experience to urgently deliver the insights, data and trial to fit your business and strategy. A partner uniquely set up to efficiently bridge preclinical studies into human trials. A partner with the ability to identify and develop your biomarker strategy to be ready for your clinical studies and development of companion diagnostics. A partner that can find the right patients and sites, understand your data and unique needs, and provide a customized strategy and successful execution plan to gather high-quality data, quickly and safely delivering your drug to the patients who greatly need life-improving and life-saving oncology treatments.
- Experience from working on more than 1035 early and late-stage oncology and hematology clinical trial studies in the past 5 years helping you to efficiently bridge preclinical studies to cancer patient trials.
- More than 300 immuno-oncology studies, including innovative CAR T therapies and adaptive trial designs.
- Co-development of drugs with an oncology companion diagnostic to help identify patients most likely to benefit from your next cancer breakthrough.
- Dedicated team of pediatric oncologists and rare disease specialists to help you navigate a complex regulatory environment while creating a truly patient centric trial approach that reduces the burden on sites and patients.
Labcorp respects your privacy.